Literature DB >> 19395181

Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion.

Xichen Zhang1, Shahreyar Shar Hashemi, Morvarid Yousefi, Chunling Gao, Joy Sheng, Jinsong Ni, Wan Wang, Jeffrey Mason, Yan-Gao Man.   

Abstract

Our recent studies showed that cell clusters overlying focal myoepithelial cell layer disruptions (FMCLD) had a significantly higher rate of ER negativity, genetic instabilities, and expression of invasion-related genes than adjacent cells within the same duct. This study attempted to determine if these cells would show aberrant E-cadherin expression, which imparts greater propensity for cell motility and invasion. Consecutive sections from breast tumors with a high frequency of FMCLD were double-immunostained for E-cadherin and a panel of related markers. The E-cadherin mRNA levels in cells overlying FMCLD and adjacent cells within the same duct were compared using real-time PCR. Nearly all the cell clusters overlying FMCLD were strongly immunoreactive for E-cadherin, whereas their adjacent counterparts within the same duct were largely negative. Cell clusters overlying FMCLD were generally arranged as tongue-like projections, "puncturing" deep into the stroma or tube-like structures that often contained red blood cells. The sub-cellular localization of E-cadherin in the above structures, however, was primarily cytoplasmic. The mRNA level of E-cadherin in cell clusters overlying FMCLD was significantly higher than that in adjacent cells within the same duct. These findings suggest that aberrant expression of E-cadherin may contribute to cell motility and invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395181     DOI: 10.1016/j.prp.2008.08.009

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.

Authors:  Qing-Xiang Amy Sang; Yan-Gao Man; You Me Sung; Zahraa I Khamis; Lihua Zhang; Mi-Hye Lee; Stephen W Byers; Ziad J Sahab
Journal:  Clin Exp Metastasis       Date:  2011-11-25       Impact factor: 5.150

2.  Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Authors:  M E Law; P E Corsino; S C Jahn; B J Davis; S Chen; B Patel; K Pham; J Lu; B Sheppard; P Nørgaard; J Hong; P Higgins; J-S Kim; H Luesch; B K Law
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

3.  Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells.

Authors:  Lea Chanson; Douglas Brownfield; James C Garbe; Irene Kuhn; Martha R Stampfer; Mina J Bissell; Mark A LaBarge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

4.  Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.

Authors:  Tanya D Russell; Sonali Jindal; Samiat Agunbiade; Dexiang Gao; Megan Troxell; Virginia F Borges; Pepper Schedin
Journal:  Am J Pathol       Date:  2015-09-04       Impact factor: 4.307

5.  Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?

Authors:  Yan-Gao Man
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

6.  Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion.

Authors:  Mary-Kate Hayward; Michael D Allen; Jennifer J Gomm; Iain Goulding; Clare L Thompson; Martin M Knight; John F Marshall; J Louise Jones
Journal:  NPJ Breast Cancer       Date:  2022-09-20

7.  Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?

Authors:  Xichen Zhang; Shahreyar Shar Hashemi; Morvarid Yousefi; Jinsong Ni; Qiuyue Wang; Ling Gao; Pengtao Gong; Chunling Gao; Joy Sheng; Jeffrey Mason; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2008-08-16       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.